Australia Warns ‘Pump and Dump’ Social Media Tactics Could Lead to Fines and Jail...
Been in and around the business for over 40 years and it's insane with what's going on these days with Youtuber's and...
Whistleblowers Make Millions (Video).
How Corporate Whistleblowers Make Millions (CNBC)
https://youtu.be/GNzCA5bwScI
THE SIEDLE LAW OFFICES
Video: The Coming Collapse Of Crypto! (Tether Again)
https://youtu.be/Odoqs0lBHLY
RELATED: Bitcoin $30,000. Time to Bargain Hunt? Read This First.
Bitcoin $30,000. Time to Bargain Hunt? Read This First.
The Bit Short: Inside Crypto’s Doomsday Machine
Scary article on Tether/Bitcoin posted on...
The Buffett Indicator. Tighten Your Safety Belts..
GDP's $22 Trillion vs Total Stock Market Value (TMC) of $50 Trillion
How Does This Compute (hint,...
The Stock Market Crash Will Destroy Lives: 2021 is the Dumbest Bubble In History...
https://youtu.be/onFT0vyiMKM
Jim Rogers: History Shows That Bitcoin Will be Outlawed if it Becomes ‘Successful.’
https://youtu.be/qmmQEm8gTcg
Peter Schiff Predictions, One Year Ago – 2020.
Dow 18,500 on March 23rd Air Date. Eventually Maybe Soon, He Will Look Genius.
...they're gonna stay on...
Is The Market Overvalued? Barron’s Round Table January 2000.
Interesting viewpoints ahead of the market drifting from near 12,000 to 7,000. Equivalent to Dow dropping to near 20,000 today.
Tesla (TSLA) Price Target Upped to $1,000. Passes $500 Billion in Valuation Today.
First Crossing $100 Billion in Value in January, Crossing $527 Today Puts the Valuation at $500 Billion. Why Own Anything Else?
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
